Trial Profile
A study investigating the muscle toxicity in raltegravir treated patients with HIV-1 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 03 Sep 2015 New trial record